Eiko Lifesciences Key Ratios

BSE: 540204

₹46.53

up-down-arrow0.23 (0.50%)

As on 03-Sep-2026IST

Market cap

info icon

₹68 Cr

Revenue (TTM)

info icon

₹59 Cr

P/E Ratio

info icon

13.4

P/B Ratio

info icon

1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -10.85 90.26 67.34 30.89 18.96
EBIT -29.22 105.11 156.50 87.75 24.23
Net Profit -5.33 53.68 116.17 72.82 31.73
EPS -5.33 47.45 82.56 52.16 9.70
Book Value -- -- 4.14 11.18 26.94
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info 2.853.0711.665.39--
Net Margin info 3.963.909.426.04--
Return on equity info 2.594.477.987.76--
Return on Capital info 3.705.25--10.08--
Return on Assets info 2.403.097.266.06--
Debt to Equity (x) info ----0.040.05--
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
--
10.08
-86.53
-11.96
4.56
Peer Median
--
12.06
18.04
20.86
19.64
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

7.98

Lower than Peers by 1.49

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
7.98
7.76
-92.01
-14.96
3.61
Peer Median
9.48
8.91
18.55
17.74
17.68
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

7.26

Higher than Peers by 1.01

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
7.26
6.06
-37.22
-7.85
1.83
Peer Median
6.24
5.64
10.29
9.17
8.40
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

11.66

Higher than Peers by 2.79

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
11.66
5.39
-45.21
-20.52
10.27
Peer Median
8.87
8.43
11.99
13.94
12.85
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

9.42

Higher than Peers by 2.87

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
9.42
6.04
-34.76
-18.22
8.25
Peer Median
6.55
5.96
10.28
8.53
7.85
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
0.00
8.11
-32.94
-14.44
12.07
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

56.13

Higher than Peers by 50.05

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
56.13
262.05
145.03
81.65
--
Peer Median
6.09
9.42
-5.01
33.50
22.67
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

124.34

Higher than Peers by 123.39

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
124.34
--
-439.80
-462.95
--
Peer Median
0.94
1.79
5.96
120.76
69.00
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

116.17

Higher than Peers by 114.05

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
116.17
164.05
-361.54
-490.99
--
Peer Median
2.12
-1.10
4.41
346.66
49.71
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

82.56

Higher than Peers by 80.69

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
82.56
135.39
-328.74
-326.44
--
Peer Median
1.88
0.15
1.72
253.30
45.61
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
--
1,828.26
-40.19
-11.47
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

0.04

Higher than Peers by 0.02

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
0.04
0.05
0.55
0.28
0.31
Peer Median
0.03
0.16
0.32
0.40
0.48
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.02

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
0.02
0.01
--
0.19
0.23
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

3.08

Higher than Peers by 1.01

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
3.08
5.25
0.54
1.02
1.28
Peer Median
2.07
2.23
1.82
1.64
1.60
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.82

Higher than Peers by 1.37

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
2.82
4.33
0.19
0.46
0.62
Peer Median
1.45
1.96
1.37
1.28
1.02
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

19.34

Higher than Peers by 10.49

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
19.34
19.55
-19.34
-4.39
3.82
Peer Median
8.85
8.85
9.78
7.20
5.99
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

34.42

Higher than Peers by 15.80

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
34.42
28.64
11.33
20.28
62.60
Peer Median
18.61
18.32
15.96
17.39
17.82
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.76

Lower than Peers by 0.04

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
0.76
0.98
1.07
0.42
0.21
Peer Median
0.80
0.84
0.92
1.54
1.15
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
--
57.98
35.79
99.91
228.50
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
--
43.54
96.92
232.74
484.30
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
--
40.04
125.83
219.36
607.63
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
--
61.48
6.89
113.29
105.17
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

13.39

Lower than Peers by 22.80

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
13.39
34.20
--
--
95.35
Peer Median
36.19
35.43
35.36
11.86
18.63
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

1.00

Lower than Peers by 1.74

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
1.00
1.27
1.32
4.43
3.37
Peer Median
2.75
2.26
3.10
1.97
2.89
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
--
--
--
--
--
Peer Median
0.27
0.30
0.32
0.66
0.42
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

6.60

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
6.60
18.09
-1.21
-35.92
47.43
Peer Median
--
23.67
19.90
9.90
17.51
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

68

Lower than Peers by 2,534

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-20
Mar-19
Mar-18
Eiko Lifesciences
68
72
4
22
19
Peer Median
2,602
920
975
485
663
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...